pyridoxal phosphate has been researched along with Cardiomyopathies in 3 studies
Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Chronic administration of a nucleotidase-resistant agonist confers a beneficial effect in the CSQ model of heart failure, apparently via an activation of the cardiac P2X receptor." | 1.34 | P2X purinergic receptor-mediated ionic current in cardiac myocytes of calsequestrin model of cardiomyopathy: implications for the treatment of heart failure. ( Cronin, C; Gongora Nieto, M; Harrison, D; Jacobson, KA; Joshi, BV; Liang, BT; Shen, JB; Sonin, D, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Spath, NB | 1 |
| Thompson, G | 1 |
| Baker, AH | 1 |
| Dweck, MR | 1 |
| Newby, DE | 1 |
| Semple, SIK | 1 |
| Shen, JB | 1 |
| Cronin, C | 1 |
| Sonin, D | 1 |
| Joshi, BV | 1 |
| Gongora Nieto, M | 1 |
| Harrison, D | 1 |
| Jacobson, KA | 1 |
| Liang, BT | 1 |
| Olbrich, HG | 1 |
| Boeker, JF | 1 |
| Rachor, S | 1 |
| Ketelsen, UP | 1 |
| Wieland, H | 1 |
| Kober, G | 1 |
| Schmidt, A | 1 |
| Mutschler, E | 1 |
1 review available for pyridoxal phosphate and Cardiomyopathies
| Article | Year |
|---|---|
Manganese-enhanced MRI of the myocardium.
Topics: Animals; Calcium Signaling; Cardiomyopathies; Contrast Media; Edetic Acid; Humans; Magnetic Resonanc | 2019 |
2 other studies available for pyridoxal phosphate and Cardiomyopathies
| Article | Year |
|---|---|
P2X purinergic receptor-mediated ionic current in cardiac myocytes of calsequestrin model of cardiomyopathy: implications for the treatment of heart failure.
Topics: Adenine Nucleotides; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Benzenesulfonates; Ca | 2007 |
Effect of magnesium pyridoxal 5-phosphate glutamate on the hamster cardiomyopathy.
Topics: Animals; Calcium; Calcium Channel Blockers; Cardiomyopathies; Cricetinae; Lipid Metabolism; Lipids; | 1992 |